Researchers at Wake Forest School of Medicine found that ALS patients with a genetic variation in the interleukin 6 (IL6) receptor gene may experience more severe symptoms and faster progression of the disease. Interleukin 6 – which has many functions in the lungs, muscle and nerves – was previously found to play a role in the severity of asthma. Click here to learn more
